Refeyn, the company behind pioneering mass photometry technologies, has developed and launched a custom software platform ...

The first application-specific module to be added to the new Streamline MP software suite is Refeyn’s Antibody Stability Module, which automatically characterizes aggregation in large batches of ...

Scientists have created a novel technology for developing antibody (M6P) conjugates without enzyme modification in vitro, ...

Proteins are essential components of cellular life, uniquely translating genetic information into a vast array of molecular ...

Lundbeck initiates a phase III trial with amlenetug for the treatment of Multiple System AtrophyMASCOT, a global phase III randomized, double-blind, placebo-controlled trial, will assess the efficacy ...

Prothena's antibody targets an area within the microtubule ... trial in early-stage Alzheimer's last year, and TauRx' tau aggregation inhibitor LMTX which wasn't able to improve on placebo in ...

Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama, Kanagawa 223-8522, Japan ...